The FDA has approved Bkemv as the first interchangeable biosimilar to Soliris to treat certain rare diseases.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA approves interchangeable biosimilar to Soliris
The FDA has approved Bkemv as the first interchangeable biosimilar to Soliris to treat certain rare diseases.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis